While endurance running is widely celebrated for its health benefits, a trailblazing study led by Tim Cannon, MD, Sheridan Director of the Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, reveals a surprising link to colon cancer risk. Featured in Runner’s World, the research opens important conversations around screening guidelines and reinforces the importance of proactive health monitoring, regardless of one’s fitness level.
Article links:
Study at a glanceInova’s incidental lung nodule program has shown a 76% reduction in time…
Catherine Wymer, PharmD, is a senior clinical pharmacist at Inova 360° Concierge Medicine. As a…
Multidisciplinary pulmonary expertise supports diagnostic evaluation, treatment planning and longitudinal care Advanced lung disease and…
Heart failure is a major focus for Inova Schar Heart and Vascular’s care transformation efforts.…
TETON pivotal studies meet primary end point In two landmark phase 3 trials, nebulized Tyvaso®…
Leesburg, VA — Inova Blood Donor Services (IBDS) invites the Loudoun County community to roll…